ENLIVEN THERAPEUTICS, INC.
Profile
Company Names
ENLIVEN THERAPEUTICS, INC.
IMARA INC.
Addresses
6200 LOOKOUT ROAD, BOULDER, CO 80301
700 TECHNOLOGY SQUARE, 3RD FLOOR, CAMBRIDGE, MA 02139
Phone Numbers
720-647-8519
617-231-6020
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2016
State Incorporated:
DELAWARE
Total Amount Raised:
$140,100,182.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2024-03-21
$90,001,086.00
$90,001,086.00
$0.00
Equity
2
2019-03-15
$44,099,096.00
$62,998,708.00
$18,899,612.00
Equity
1
2016-04-13
$6,000,000.00
$30,999,971.00
$24,999,971.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRISTOPH
M.
ADAMS
EXECUTIVE OFFICER, DIRECTOR
METTE
KIRSTINE
AGGER
DIRECTOR
RAHUL
BALLAL
DIRECTOR, EXECUTIVE OFFICER
JAKE
BAUER
DIRECTOR
DAVID
BONITA
DIRECTOR
VIEWRAY INC
| ENOBIA PHARMA CORP
| LOXO ONCOLOGY, INC.
| TRICIDA, INC.
| VIEWRAY, INC.
| ACUTUS MEDICAL, INC.
| SI-BONE, INC.
| PRELUDE THERAPEUTICS INC.
| PRELUDE THERAPEUTICS INC
| IMARA INC.
| ORBIMED PARTNERS II, L.P.
| ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.
| ORBIMED GLOBAL HEALTHCARE FUND, L.P.
| TREELINE BIOSCIENCES, INC.
| IKENA ONCOLOGY, INC.
| ADELA, INC.
| THROMBOLEX, INC.
MARK
CHIN
DIRECTOR
OPTIKIRA, LLC
| ITERUM THERAPEUTICS LTD
| HARPOON THERAPEUTICS, INC.
| AURA BIOSCIENCES, INC.
| VELOSBIO INC.
| IMARA INC.
| ITERUM THERAPEUTICS BERMUDA LTD
| ITERUM THERAPEUTICS PLC
| ITERUM THERAPEUTICS US LTD
| ITERUM THERAPEUTICS US HOLDING LTD
| ITERUM THERAPEUTICS INTERNATIONAL LTD
| SORRISO PHARMACEUTICALS, INC.
| ENSOMA, INC.
| AVENZOAR PHARMACEUTICALS, INC.
BARBARA
DALTON
DIRECTOR
CARL
GOLDFISCHER
DIRECTOR
RISHI
GUPTA
DIRECTOR
GELESIS INC
| SIENTRA, INC.
| AVITIDE, INC.
| SYMBIOMIX THERAPEUTICS, LLC
| DIMENSION THERAPEUTICS, INC.
| MEVES PHARMACEUTICALS, INC.
| ATTENUA, INC.
| TURNSTONE BIOLOGICS CORP.
| GOLDEN TEAK CAPITAL L.P.
| NEUROPACE INC
| VERONA PHARMA PLC
| CHARM THERAPEUTICS INC.
| DELFI DIAGNOSTICS, INC.
| AER THERAPEUTICS, INC.
| HELICORE BIOVENTURES I, INC.
| ENLIVEN THERAPEUTICS, INC.
| WILSHIRE SELECTIVE OPPORTUNITIES PROGRAM SPC - WILSOP SEGREGATED PORTFOLIO 5
RICHARD
HEYMAN
DIRECTOR
ROBERT
HOPFNER
DIRECTOR
DAVID
MOTT
DIRECTOR
3-V BIOSCIENCES, INC.
| TESARO, INC.
| ARDELYX, INC.
| ZYNGENIA, INC.
| OMTHERA PHARMACEUTICALS, INC.
| MERSANA THERAPEUTICS INC
| CYDAN, LLC
| EDIMER PHARMACEUTICALS, INC.
| PROSENSA HOLDING N.V.
| ADAPTIMMUNE LTD
| MERSANA THERAPEUTICS, INC.
| XTUIT PHARMACEUTICALS, INC.
| IMARA INC.
| COMPLEXA INC.
| CYDAN II, INC.
| TIBURIO THERAPEUTICS INC.
SARA
NAYEEM
DIRECTOR
ANISH
PATEL
EXECUTIVE OFFICER
ANDREW
PHILLIPS
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-03-21
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

